Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
about
Folic Acid Supplementation for Rheumatoid Arthritis Patients on Methotrexate: The Good Gets BetterOutcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature reviewMercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fictionManaging the drug treatment of rheumatoid arthritis.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.In vitro inhibition of HUVECs by low dose methotrexate - insights into oral adverse events.Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis.Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate.Laser acupuncture versus reflexology therapy in elderly with rheumatoid arthritis.Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.Being as Normal as Possible: How Young People Ages 16-25 Years Evaluate the Risks and Benefits of Treatment for Inflammatory Arthritis.Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.Folic acid or folinic acid for reducing side effects of methotrexate for people with rheumatoid arthritis.Leveraging the electronic health record to improve quality and safety in rheumatology.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis.Quantifiable risk-benefit assessment of micronutrients: From theory to practice.Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.Editorial for issue 3 of 2013, Journal of Evidence Based Medicine.Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.A sandwich substrate for ultrasensitive and label-free SERS spectroscopic detection of folic acid / methotrexate.
P2860
Q24200922-DF0D8204-70FF-4467-98BC-82309D284A76Q26995202-4BF9E254-22D8-4845-840C-0CE984EFA9ECQ27023839-A0830ACC-D523-483A-9CFE-991642F442BBQ33611369-3AB31711-BACB-4565-BA47-19D9B3CE8101Q33654733-842302D1-76D4-4920-99AE-38F0D7998F67Q33661406-3496A39A-927F-434B-A31C-766B21724627Q34642567-E9D25E92-1FF2-46F7-A6DB-1F82AFC692BDQ35154188-24CC6B64-F60F-4994-A016-E926E5B91914Q35236926-8E2086C5-DC1E-4A7E-AF70-013B2BA8781AQ35789299-3E0A6892-EF2B-4476-9BD8-BF66EB1B2D48Q36225180-CDC186C5-F990-44D8-A567-12801568529EQ36357476-052ECBEF-2BF5-42E4-B313-E0DEF75C90F4Q36372720-45221FF0-2FA5-4B68-85E2-C43F7219F361Q37296221-3F69F5D9-C4AF-4690-BBA2-E08550801443Q37745676-1FC1AC50-ED2F-4B31-8053-C7BB7C17FBADQ38170157-E7A7A73F-770F-4A4F-99A9-C2E088A0C272Q38368489-03B83E29-998F-43A1-ABEC-37690FCF1D34Q38563075-34A402C6-FE0E-48BA-A6D9-BDA96BD3399CQ39383677-7E3553F3-C977-429F-B677-A0EB3C35E30CQ39760647-F138B0E3-A3E0-4956-B54E-2EDCDC4406ECQ40048725-6D9E160A-DC07-46B6-B403-59AA32F223A6Q43895401-C34B686B-5802-454C-9410-F1F386ABC273Q52595619-51AC1605-3707-4D74-B2E0-207A502022C1Q53545142-E925DA17-4C24-43A7-BA05-93760214FD28
P2860
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@ast
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en-gb
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@nl
type
label
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@ast
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en-gb
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@nl
prefLabel
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@ast
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en-gb
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@nl
P2093
P2860
P50
P1476
Folic acid and folinic acid fo ...... exate for rheumatoid arthritis
@en
P2093
George A Wells
Michael V Swinden
Tamara Rader
Wanruchada Katchamart
Zulma Ortiz
P2860
P356
10.1002/14651858.CD000951.PUB2
P577
2013-05-31T00:00:00Z